股東特別大會之紀錄日期 香港交易及結算所有限公司、香港聯合交易所有限公司(J聯交所)及香港中央 結 算 有 限 公 司 對 本 公 告 的 內 容 概 不 負 責 ，對 其 準 確 性 或 完 整 性 亦 不 發 表 聲 明, 並 明 確 表 示 概 不 會 就 因 本 公 告 全 部 或 任 何 部 分 內 容 而 產 生 或 因 依 賴 該 等 內 容 而 引致的任何損失承擔任何責任。 Fortior Technology (Shenzhen) Co., Ltd. 峰 科技(深圳)股份有限公司 (於中華人民共和國註冊成立的股份有限公司) (股份代號:1304) 峰昭科技(深圳)股份有限公司(「本公司」達此宣佈,本公司將於2025年8月15日 下 午 一 時 三 十 分 召 開 股 東 特 別 大 會( 股 東 特 別 大 會 ), 而 釐 定 股 東 出 席 股東 特 別 大 會 並 於 會 上 投 票 的 記 錄 日 期 為 2025年8月 11日。預計 將 於 股 東 特 別 大 會 提 星 及 審 議 的 決 議 案 包括(i)委 任 本 公 司 2025年 度 A 股 的 核 數 師;(ii)委 ...

证券代码：688279 证券简称：峰岹科技 公告编号：2025-037 峰岹科技（深圳）股份有限公司 关于悉数行使超额配售权的公告 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容的 真实性、准确性和完整性依法承担法律责任。 特此公告。 峰岹科技（深圳）股份有限公司董事会 2025年7月25日 经香港联合交易所有限公司（以下简称"香港联交所"） 批准，峰岹科技（深圳）股份有限公司（以下 简称"公司"）发行的18,744,400股（行使超额配售权之前） 境外上市股份（H 股）已于2025年7月9日在 香港联交所主板挂牌并上市交易（以下简称"本次发行上市"）。公司H股股票简称为"FORTIOR"，股份 代号为"1304"，具体内容详见公司于2025年7月10日在上海证券交易所网站（www.sse.com.cn）及指定 媒体披露的《峰岹科技（深圳）股份有限公司关于境外上市股份（H股）挂牌并上市交易的公告》（公 告编号：2025-035）。 根据本次发行方案，公司同意由保荐人兼整体协调人（为其自身及代表国际承销商）于2025年7月24日 悉数行使超额配售权，按发售价每股120. ...

证券代码：688279 证券简称：峰岹科技 公告编号：2025-037 特此公告。 峰岹科技（深圳）股份有限公司董事会 根据本次发行方案，公司同意由保荐人兼整体协调人（为其自身及代表国际 承销商）于 2025 年 7 月 24 日悉数行使超额配售权，按发售价每股 120.5 港元（不 包括经纪佣金、香港证监会交易征费、香港联交所交易费及香港会财局交易征费） 发行 2,811,600 股 H 股股份。前述超额配售权悉数行使后，本次发行上市的 H 股 由 18,744,400 股增加至 21,556,000 股。 峰岹科技（深圳）股份有限公司 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 经香港联合交易所有限公司（以下简称"香港联交所"） 批准，峰岹科技（深 圳）股份有限公司（以下简称"公司"）发行的 18,744,400 股（行使超额配售权 之前） 境外上市股份（H 股）已于 2025 年 7 月 9 日在香港联交所主板挂牌并 上市交易（以下简称"本次发行上市"）。公司 H 股股票简称为"FORTIOR"，股 份代号为"13 ...

关于悉数行使超额配售权的公告 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 证券代码：688279 证券简称：峰岹科技 公告编号：2025-037 峰岹科技（深圳）股份有限公司 峰岹科技（深圳）股份有限公司董事会 2025 年 7 月 25 日 经香港联合交易所有限公司（以下简称"香港联交所"） 批准，峰岹科技（深 圳）股份有限公司（以下简称"公司"）发行的 18,744,400 股（行使超额配售权 之前） 境外上市股份（H 股）已于 2025 年 7 月 9 日在香港联交所主板挂牌并 上市交易（以下简称"本次发行上市"）。公司 H 股股票简称为"FORTIOR"，股 份代号为"1304"，具体内容详见公司于 2025 年 7 月 10 日在上海证券交易所网 站（www.sse.com.cn）及指定媒体披露的《峰岹科技（深圳）股份有限公司关于 境外上市股份（H 股）挂牌并上市交易的公告》（公告编号：2025-035）。 根据本次发行方案，公司同意由保荐人兼整体协调人（为其自身及代表国际 承销商）于 2025 年 7 月 2 ...

Core Viewpoint - Since 2025, insurance companies have triggered 21 investment events involving stock acquisitions, surpassing the total number of such events in the previous year [4]. Group 1: Investment Activities - The A-share market has been experiencing upward fluctuations, and the Hong Kong stock market is recovering, leading to increased activity from insurance funds in the capital markets [2]. - In July 2025, Zhongyou Insurance announced its acquisition of shares in Green Power Environmental (01330.HK), triggering a stock acquisition disclosure [3][8]. - Other insurance companies, such as Xintai Life and Lianan Life, also disclosed stock acquisitions in July 2025 [9] [10]. Group 2: Specific Investment Cases - Zhongyou Insurance purchased 726,000 shares of Green Power Environmental, increasing its holdings to 20.51 million shares, representing 5.0722% of the company's H-share capital [8]. - Xintai Life increased its holdings in Hualing Steel (000932.SZ) to 345 million shares, raising its ownership from 4.99% to 5.00% [10]. - Lianan Life acquired 1.1 million shares of Jiangnan Water (601199.SH), increasing its stake from 4.91% to 5.03% [10]. Group 3: Financial Data and Trends - As of June 30, 2025, Zhongyou Insurance reported a net buy of over 90 billion yuan in public market equity investments [6]. - Xintai Life's equity assets amounted to 565.78 billion yuan, accounting for 19.07% of its total assets as of June 30, 2025 [10]. - Lianan Life's equity assets were reported at 205.6 billion yuan, making up 16.29% of its total assets as of May 31, 2025 [10]. Group 4: Market Dynamics and Regulatory Environment - The current wave of stock acquisitions by insurance companies is driven by a preference for high-dividend stocks, particularly in sectors like banking, public utilities, and pharmaceuticals, with an average dividend yield of 4.6% since 2024 [14]. - The downward trend in interest rates has increased investment pressure on insurance companies, prompting them to seek stable long-term investment returns through frequent stock acquisitions [15]. - Regulatory changes have encouraged insurance funds to engage in long-term equity investments, with new guidelines introduced to assess net asset returns over extended periods [19].

Core Viewpoint - The insurance industry is experiencing a significant wave of equity stakes, with a notable increase in the number of share acquisitions by insurance companies, indicating a strategic shift in asset allocation towards high-dividend stocks and long-term equity investments [2][10][15]. Group 1: Recent Activities - Recently, Taikang Life participated as a cornerstone investor in the IPO of Fengcai Technology, investing $25 million for an 8.69% stake [3]. - In July alone, insurance companies have made three significant equity acquisitions, with Taikang Life being the latest [4]. - As of July 20, insurance companies have made a total of 20 equity acquisitions this year, surpassing the total for 2023 and matching the total for 2024 [2][7]. Group 2: Investment Trends - The current wave of equity acquisitions began in 2024 and has shown no signs of slowing down, with banks being the most frequently targeted sector [8][9]. - The insurance sector has seen three waves of equity acquisition trends over the past decade, with the current wave driven by the need for stable cash returns in a low-interest-rate environment [10][11]. - High-dividend stocks are particularly attractive to insurance companies, as they provide better yields compared to long-term bonds [11][12]. Group 3: Financial Performance - As of March 31, 2023, Xintai Life had total assets of 315.79 billion yuan, with equity assets accounting for 19.07% of total assets [5]. - Li'an Life reported total assets of 126.19 billion yuan as of March 31, 2023, with equity assets making up 16.29% of total assets [6]. - The financial performance of insurance companies is being optimized through strategic equity acquisitions, which can enhance the stability of profit reports under new accounting standards [15][19]. Group 4: Regulatory Environment - Recent regulatory changes are encouraging insurance companies to adopt long-term investment strategies, with a new five-year assessment framework introduced to evaluate performance [17][18]. - The Ministry of Finance's new guidelines aim to enhance the role of insurance funds in providing long-term capital to the market, promoting stability and healthy development [19].

Core Viewpoint - The announcement details a passive dilution of shareholding percentages for major shareholders of Fengcai Technology (Shenzhen) Co., Ltd. due to the issuance of H shares, which has resulted in a decrease in their respective ownership stakes without triggering mandatory tender offer obligations [1][2]. Group 1: Shareholding Changes - The shareholding percentage of Fengcai Technology (Hong Kong) Co., Ltd. decreased from 39.52% to 32.86% [1]. - The shareholding percentage of Xinyun Technology (Shenzhen) Co., Ltd. decreased from 12.10% to 10.06% [1]. - The shareholding percentage of Shanghai Huaxin Venture Capital Partnership (Limited Partnership) decreased from 5.95% to 4.94% [1][4]. Group 2: Compliance and Obligations - The changes in shareholding do not violate any existing commitments, intentions, or plans made by the shareholders [1][2]. - The changes do not trigger any mandatory tender offer obligations [2][4]. Group 3: Additional Information - The passive dilution is a result of the company's issuance of H shares and the subsequent increase in total share capital [2][5]. - The company will fulfill its information disclosure obligations in accordance with relevant regulations [5].

证券代码：688279 证券简称：峰岹科技 公告编号：2025-036 峰岹科技（深圳）股份有限公司 关于持股 5%以上股东持股比例被动稀释跨越 5%整 数倍及触及 1%刻度的提示性公告 投资者峰岹科技（香港）有限公司及其一致行动人芯运科技（深圳）有限 公司、上海华芯创业投资合伙企业（有限合伙）、微禾创业投资（珠海横琴）有 限公司及其一致行动人 ZHANG QUN 保证向本公司提供的信息真实、准确、完 整，没有虚假记载、误导性陈述或重大遗漏。 本公司董事会及全体董事保证公告内容与信息披露义务人提供的信息一致。 重要内容提示： 1、峰岹科技（香港）有限公司及其一致行动人芯运科技（深圳）有限公 司 | 权益变动方向 | 比例增加□ | | 比例减少☑ | | --- | --- | --- | --- | | 权益变动前合计比例 | 39.52% | | | | 权益变动后合计比例 | 32.86% | | | | 本次变动是否违反已作出的承 诺、意向、计划 | 是□ | 否☑ | | | 是否触发强制要约收购义务 | 是□ | 否☑ | | | 2、上海华芯创业投资合伙企业（有限合伙） | | | | 本次权益 ...

Group 1: Company Listings and Performance - Both Lens Technology and Peak Innovation successfully listed on the Hong Kong Stock Exchange, adding to the A+H market segment [1] - On their first trading day, Lens Technology's stock closed up 9.13%, while Peak Innovation's stock rose by 16.02% [1] - Lens Technology's A-shares traded at a premium of 25.49% over H-shares, and Peak Innovation's A-shares had a premium of 43.04% over H-shares on the first day of trading [1] Group 2: Fundraising and Investor Interest - Lens Technology's global offering consisted of 262 million shares at an issue price of HKD 18.18 per share, raising a total of HKD 4.768 billion [1] - The IPO of Lens Technology received significant interest, with a subscription rate of 462.76 times for the public offering and 16.68 times for the international offering [1] - Peak Innovation raised a total of HKD 2.259 billion with an issue price of HKD 120.5 per share, attracting cornerstone investors such as Taikang Life and Huaxia Fund [2] Group 3: Company Profiles and Market Position - Lens Technology is a leading provider of precision manufacturing solutions for the consumer electronics and smart automotive industries, offering a wide range of products including glass covers and electronic components [2] - Peak Innovation specializes in the design and development of BLDC motor drive control chips, holding a 4.8% market share in China's BLDC motor control chip market, ranking sixth [3] Group 4: Market Trends and Future Outlook - The trend of A+H listings is expected to continue, with 47 new listing applications recorded in the first half of 2025, compared to only 5 for the entire year of 2024 [4] - A+H listings are anticipated to enhance the quality of assets available in the market, with an estimated additional financing scale of approximately HKD 340 billion expected if the queued companies complete their listings by mid-2025 [4]

Core Viewpoint - The Hong Kong Stock Exchange (HKEX) is experiencing a significant surge in IPO activities, with multiple companies successfully listing and attracting substantial investments, indicating a revitalized market confidence and a robust pipeline for future listings [2][7][10]. Group 1: Recent IPO Activities - On July 9, five companies including Lens Technology and Geek+ collectively listed on the HKEX, creating a lively atmosphere and showcasing the exchange's appeal [2][4]. - Lens Technology, with a market capitalization exceeding 110 billion HKD, completed its IPO in just 100 days, marking a record speed for the HKEX [4]. - Geek+, a robotics unicorn, achieved a market valuation of 22 billion HKD upon listing, highlighting the growing interest in technology-driven companies [4][5]. Group 2: Market Trends and Statistics - Over 40 companies successfully completed IPOs on the HKEX in the first half of the year, raising a total of 1,067 billion HKD, a dramatic increase of 688.56% compared to the previous year [7]. - Notable IPOs include CATL, which reached a market value of 1.3 trillion HKD, and other major players like Heng Rui Medicine and Hai Tian Flavor, each raising over 10 billion HKD [7]. - The HKEX is preparing for over 100 upcoming IPOs, with around 200 applications currently received, indicating a strong pipeline for future listings [7][10]. Group 3: Investor Sentiment and Market Dynamics - There is a renewed confidence in the HKEX, with institutional investors actively seeking opportunities to list companies, contrasting sharply with previous years' challenges [10][11]. - In the first half of the year, 36 out of 42 listed companies had cornerstone investors, accounting for 43.7% of total IPO fundraising, demonstrating strong backing from major investment firms [10]. - The successful performance of cornerstone investors in recent listings has further fueled interest in the HKEX as a viable platform for capital raising [11].